LGALS1 and pancreatic neoplasm: Notably, The MTAI contrast of pancreatic tumors after injection of anti-Gal1-Fe3O4 nanoparticles increased by about 2.2- fold compared to pre-injection (standard deviation, 0.13) (Figure 5E).